Mount Sinai Hospital: Polypill Reduces Cardiovascular Mortality by 33 Percent in Patients Treated After a Heart Attack
August 27, 2022
August 27, 2022
NEW YORK, Aug. 27 (TNSjou) -- Mount Sinai Hospital issued the following news release:
A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population. These are findings from the SECURE trial led by Valentin Fuster . . .
A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population. These are findings from the SECURE trial led by Valentin Fuster . . .